Sumansetron Kit
Product Images NDC 59088-772

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumansetron (NDC 59088-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puretek Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Sumansetron kit packaging label showing Sumatriptan Tablets USP 50 mg (9 tablets) and Ondansetron Tablets USP 4 mg (30 tablets). Label includes NDC 59088-772-00 and states Rx Only. Packaged by PureTek Corporation, Panorama City, CA.*

FDA Label Image

2 (Structual Formula)

Chemical structure diagram of sumatriptan succinate and ondansetron active ingredients depicted with molecular bonds and atoms, including a hydrochloride and water component (HCl·2H₂O).*

FDA Label Image

Fig1 (Fig1)

A line graph depicting estimated probability of response over time in minutes from the first dose, comparing placebo and three dosages (25 mg, 50 mg, 100 mg). The y-axis shows percentage response probability, while the x-axis shows time up to 240 minutes. Different symbols represent each dosage group.*

FDA Label Image

Fig2 (Fig2)

A line graph showing the estimated probability of renal survival over time in hours after the initial dose. The graph includes data for placebo and three dosages: 25 mg, 50 mg, and 100 mg, with survival probability increasing over 24 hours for all groups.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredients sumatriptan succinate and ondansetron, as depicted in the image associated with the Sumansetron kit by PureTek Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.